-
World’s First Malaria Vaccine Gets Regulatory Go-Ahead, Faces WHO Review
The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease.
- Categories
- Health Care
- Tags
- vaccines
-
Trying to Get the World Unhooked From Hookworm
This week, Goats and Soda learned of a pretty icky research experiment taking place in our nation's capital. People are becoming infected with hookworm in the name of science, as researchers seek to develop a vaccine.
- Categories
- Health Care
- Tags
- vaccines
-
Health Specialists Call for $2 Billion Global Fund for Vaccines
Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus.
- Categories
- Health Care
-
Sanofi Preps for ‘Profitable’ Dengue Vaccine Rollout in 20 Countries
With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only be a big deal for patients in the developing world--it'll be a highly profitable product to boot.
- Categories
- Health Care
-
Sanofi Unveils Restructuring Plans, Prunes Business Units
Sanofi’s (SNY - Analyst Report) newly appointed Chief Executive Officer Olivier Brandicourt, after just three months of being at the helm, has made a big move by declaring plans to reorganize its business. Brandicourt intends to restructure the seven existing business units into five global business units. Along with its existing vaccines unit – Sanofi Pasteur – and the animal health business – Merial, the company plans to create three new global business units, namely, General Medicines & Emerging Markets, Specialty Care and Diabetes & Cardiovascular.
- Categories
- Health Care
- Tags
- vaccines
-
Caveats, Costs and Complexities Shadow First Malaria Vaccine
It's a showpiece drug that has the potential to end a disease that kills half a million African children a year. Yet even before it wins a license, the world's first malaria vaccine has lost some of its sheen.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Pharma Price Control Has Stunted Innovation, Study Finds
Consumers may be happy at a cut in medicine bills but the government's price control measures have forced many brands out of the "unviable" pharmaceutical market, resulting in a drastic slowdown in new launches in the last five years.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Cautious Optimism: Calculating the Actual Value of a Global Health Game Changer
We all know that vaccines have had huge success in protecting children from deadly diseases. However, the health benefits of vaccines have not been shared equally across the globe.
- Categories
- Health Care
- Tags
- vaccines
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.